BrightGene Bio Stock Forecast - Polynomial Regression
| 688166 Stock | 29.55 0.68 2.36% |
The Polynomial Regression forecasted value of BrightGene Bio Medical on the next trading day is expected to be 27.78 with a mean absolute deviation of 0.98 and the sum of the absolute errors of 59.64. BrightGene Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast BrightGene Bio stock prices and determine the direction of BrightGene Bio Medical's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of BrightGene Bio's historical fundamentals, such as revenue growth or operating cash flow patterns.
BrightGene |
BrightGene Bio Polynomial Regression Price Forecast For the 15th of January 2025
Given 90 days horizon, the Polynomial Regression forecasted value of BrightGene Bio Medical on the next trading day is expected to be 27.78 with a mean absolute deviation of 0.98, mean absolute percentage error of 1.86, and the sum of the absolute errors of 59.64.Please note that although there have been many attempts to predict BrightGene Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BrightGene Bio's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BrightGene Bio Stock Forecast Pattern
| Backtest BrightGene Bio | BrightGene Bio Price Prediction | Buy or Sell Advice |
BrightGene Bio Forecasted Value
In the context of forecasting BrightGene Bio's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BrightGene Bio's downside and upside margins for the forecasting period are 24.04 and 31.51, respectively. We have considered BrightGene Bio's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of BrightGene Bio stock data series using in forecasting. Note that when a statistical model is used to represent BrightGene Bio stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.732 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.9777 |
| MAPE | Mean absolute percentage error | 0.0307 |
| SAE | Sum of the absolute errors | 59.6404 |
Predictive Modules for BrightGene Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BrightGene Bio Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for BrightGene Bio
For every potential investor in BrightGene, whether a beginner or expert, BrightGene Bio's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BrightGene Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BrightGene. Basic forecasting techniques help filter out the noise by identifying BrightGene Bio's price trends.BrightGene Bio Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BrightGene Bio stock to make a market-neutral strategy. Peer analysis of BrightGene Bio could also be used in its relative valuation, which is a method of valuing BrightGene Bio by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BrightGene Bio Medical Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BrightGene Bio's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BrightGene Bio's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BrightGene Bio Market Strength Events
Market strength indicators help investors to evaluate how BrightGene Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BrightGene Bio shares will generate the highest return on investment. By undertsting and applying BrightGene Bio stock market strength indicators, traders can identify BrightGene Bio Medical entry and exit signals to maximize returns.
| Accumulation Distribution | 216050.0 | |||
| Daily Balance Of Power | 0.7083 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 29.2 | |||
| Day Typical Price | 29.32 | |||
| Price Action Indicator | 0.69 | |||
| Period Momentum Indicator | 0.68 |
BrightGene Bio Risk Indicators
The analysis of BrightGene Bio's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BrightGene Bio's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting brightgene stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 3.74 | |||
| Variance | 13.98 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in BrightGene Stock
BrightGene Bio financial ratios help investors to determine whether BrightGene Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BrightGene with respect to the benefits of owning BrightGene Bio security.